BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 29123266)

  • 1. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
    Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
    Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
    Pei XH; Lv XQ; Li HX
    Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
    Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
    Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crosstalk between epithelial-mesenchymal transition and castration resistance mediated by Twist1/AR signaling in prostate cancer.
    Shiota M; Itsumi M; Takeuchi A; Imada K; Yokomizo A; Kuruma H; Inokuchi J; Tatsugami K; Uchiumi T; Oda Y; Naito S
    Endocr Relat Cancer; 2015 Dec; 22(6):889-900. PubMed ID: 26311513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.
    Liu Y; Mayo MW; Xiao A; Hall EH; Amin EB; Kadota K; Adusumilli PS; Jones DR
    Mol Cell Biol; 2015 Jan; 35(1):303-17. PubMed ID: 25368381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The twist box domain is required for Twist1-induced prostate cancer metastasis.
    Gajula RP; Chettiar ST; Williams RD; Thiyagarajan S; Kato Y; Aziz K; Wang R; Gandhi N; Wild AT; Vesuna F; Ma J; Salih T; Cades J; Fertig E; Biswal S; Burns TF; Chung CH; Rudin CM; Herman JM; Hales RK; Raman V; An SS; Tran PT
    Mol Cancer Res; 2013 Nov; 11(11):1387-400. PubMed ID: 23982216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
    Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
    Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SOX5 promotes epithelial-mesenchymal transition and cell invasion via regulation of Twist1 in hepatocellular carcinoma.
    Wang D; Han S; Wang X; Peng R; Li X
    Med Oncol; 2015 Feb; 32(2):461. PubMed ID: 25572815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The long noncoding RNA TUG1 is required for TGF-β/TWIST1/EMT-mediated metastasis in colorectal cancer cells.
    Shen X; Hu X; Mao J; Wu Y; Liu H; Shen J; Yu J; Chen W
    Cell Death Dis; 2020 Jan; 11(1):65. PubMed ID: 31988275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY; Teng SC; Cheng TH; Wu KJ
    Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Sox6 as a regulator of pancreatic cancer development.
    Jiang W; Yuan Q; Jiang Y; Huang L; Chen C; Hu G; Wan R; Wang X; Yang L
    J Cell Mol Med; 2018 Mar; 22(3):1864-1872. PubMed ID: 29369542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statin inhibits large hepatitis delta antigen-Smad3 -twist-mediated epithelial-to-mesenchymal transition and hepatitis D virus secretion.
    Liang YJ; Sun CP; Hsu YC; Chen YW; Wang IA; Su CW; Tao MH; Wu JC
    J Biomed Sci; 2020 May; 27(1):65. PubMed ID: 32434501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.
    Tran DD; Corsa CA; Biswas H; Aft RL; Longmore GD
    Mol Cancer Res; 2011 Dec; 9(12):1644-57. PubMed ID: 22006115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin restrains TGF-β1-induced epithelial-mesenchymal transition by inhibiting Twist1 and regulating E-cadherin expression.
    Feng J; Song D; Jiang S; Yang X; Ding T; Zhang H; Luo J; Liao J; Yin Q
    Biochem Biophys Res Commun; 2018 Mar; 498(1):132-138. PubMed ID: 29425820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLCε regulates prostate cancer mitochondrial oxidative metabolism and migration via upregulation of Twist1.
    Fan J; Fan Y; Wang X; Niu L; Duan L; Yang J; Li L; Gao Y; Wu X; Luo C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):337. PubMed ID: 31383001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway.
    Wang YP; Yu GR; Lee MJ; Lee SY; Chu IS; Leem SH; Kim DG
    Hepatology; 2013 Oct; 58(4):1349-61. PubMed ID: 23696034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
    Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
    Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
    Nam EH; Lee Y; Moon B; Lee JW; Kim S
    Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
    Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
    Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twist induces epithelial-mesenchymal transition in cervical carcinogenesis by regulating the TGF-β/Smad3 signaling pathway.
    Fan Q; Qiu MT; Zhu Z; Zhou JH; Chen L; Zhou Y; Gu W; Wang LH; Li ZN; Xu Y; Cheng WW; Wu D; Bao W
    Oncol Rep; 2015 Oct; 34(4):1787-94. PubMed ID: 26239019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.